Lansodor (Lansoprazole)

Lansoprazole blocks the H+/K+ ATPase enzyme, also known as the gastric proton pump, located on the surface of parietal cells in the stomach. By irreversibly inhibiting this pump, it prevents the final step of acid secretion, leading to a sustained reduction in gastric acidity and creating an environment that promotes healing of acid‑related lesions.

The specific dose and duration of Lansodor therapy are determined by the prescribing healthcare professional based on the patient’s diagnosis, severity of disease, age, renal function and other individual factors. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

Safety data for lansoprazole in pregnancy and lactation are limited, and the product’s pregnancy category is listed as unknown. The drug should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Lansodor (lansoprazole) belongs to the proton pump inhibitor class, which provides more potent and longer‑lasting acid suppression than H2‑receptor antagonists such as ranitidine. Compared with other PPIs, lansoprazole has a similar efficacy profile but may differ slightly in pharmacokinetics, drug‑interaction potential and individual patient tolerance.

Lansodor should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keeping the tablets in a dry place helps maintain their stability and potency throughout the shelf life.

Lansodor is taken orally, usually as a whole tablet swallowed with a glass of water. It is generally recommended to take the medication before a meal, but patients should follow the specific timing instructions provided by their prescriber.

Serious but rare risks include severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated diarrhea, Stevens‑Johnson syndrome, significant liver enzyme elevations, low magnesium levels with long‑term use, and acute pancreatitis. Patients should seek immediate medical attention if they experience symptoms like rash, persistent diarrhea, abdominal pain, or signs of infection.

Lansodor is contraindicated in individuals with known hypersensitivity to lansoprazole or any component of the formulation. Caution is also advised for patients with severe liver disease, those taking medications that have major interactions (e.g., clopidogrel), and patients with a history of allergic reactions to other proton pump inhibitors.